Fundraising Fox
/Companies
Sign in

ArkeaBio

4 known investors

Find your way into ArkeaBio

427 people in our graph can introduce you to the ArkeaBio team.

Sign up to see every warm intro you have to ArkeaBio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ArkeaBio team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

ArkeaBio develops a methane-reducing vaccine for cattle that lowers agricultural emissions without disrupting farm operations, targeting livestock producers to enable low-carbon dairy and beef production. The vaccine activates a natural immune response in ruminants and integrates seamlessly with existing farming practices.

AgTechBiotechClimate Tech

Founders & leadership

FWFrank Wooten
Frank WootenChief Executive OfficerCEO of ArkeaBio, which develops a methane-reducing vaccine for cattle to lower agricultural emissions.
ZSZach Serber
Zach SerberChief Technology Officer
CSColin South
Colin SouthChief Business OfficerHe has held executive and technology leadership roles across food, life sciences, and energy sectors, with background in engineering and science combined with business strategy and commercialization expertise.

Investors · 4

NYA Ventureslisted by NYA VenturesCalgary

How we know: NYA Ventures's portfolio page · Not right? Tell us

Rabo Corporate Venturinglisted by Rabo Corporate VenturingUtrecht · $1.1M – $5.5M

How we know: Rabo Corporate Venturing's portfolio page · Not right? Tell us

AgriZeroNZreported

How we know: agfundernews.com · Not right? Tell us

Funding

SEC filings, press & company announcements

$26.5M disclosed across 1 of 4 rounds · 2022–2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

ArkeaBio Names Frank Wooten CEO, Closes A1 Fundingarkeabio.com · Sep 2025

Frequently asked questions

What does ArkeaBio do?
ArkeaBio develops a methane-reducing vaccine for cattle that lowers agricultural emissions without disrupting farm operations, targeting livestock producers to enable low-carbon dairy and beef production. The vaccine activates a natural immune response in ruminants and integrates seamlessly with existing farming practices.
Who are ArkeaBio's investors?
ArkeaBio's investors include Breakthrough Energy Ventures, NYA Ventures, Rabo Corporate Venturing, AgriZeroNZ.
How much funding has ArkeaBio raised?
ArkeaBio has disclosed $26.5M raised across 1 of its 4 known rounds.